<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Naproxen</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00788</strong>&#160; (APRD01135)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00788/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00788/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00788.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00788.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00788.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00788.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00788.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00788">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Naprolag</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>IS</td></tr><tr><td>Naproxen</td><td>German</td><td>INN</td></tr><tr><td>Naprox&#232;ne</td><td>French</td><td>INN</td></tr><tr><td>Naproxeno</td><td>Spanish</td><td>INN</td></tr><tr><td>Naproxenum</td><td>Latin</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Naproxen sodium</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000949/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000949/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000949">DBSALT000949</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Aleve</td><td>Bayer</td></tr><tr><td>Alidase</td><td>Laboratorios</td></tr><tr><td>Alpoxen</td><td>Actavis</td></tr><tr><td>Alpron</td><td>Aldril</td></tr><tr><td>Anaprox</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Apain</td><td>Marvic</td></tr><tr><td>Apranax</td><td>Roche</td></tr><tr><td>Apronax</td><td>Bayer</td></tr><tr><td>Bonyl</td><td>Orion</td></tr><tr><td>Bruproxen</td><td>Bruluart</td></tr><tr><td>Bumaflex N</td><td>Nycomed</td></tr><tr><td>Congex</td><td>Buxton</td></tr><tr><td>Debril</td><td>Monserrat</td></tr><tr><td>Deproxen</td><td>Drug International</td></tr><tr><td>Dysmenalgit</td><td>Krewel Meuselbach</td></tr><tr><td>Ec-naprosyn</td><td>Roche</td></tr><tr><td>Emox</td><td>Emo-Farm</td></tr><tr><td>Emoxen</td><td>EMO</td></tr><tr><td>Eurogesic</td><td>Saval</td></tr><tr><td>Fabralgina</td><td>Fabra</td></tr><tr><td>Feminax Ultra</td><td>Bayer</td></tr><tr><td>Flogotone</td><td>Interpharma</td></tr><tr><td>Gerinap</td><td>Gerard</td></tr><tr><td>Honlow</td><td>Panion &amp; BF</td></tr><tr><td>Improstan</td><td>Farmacoop</td></tr><tr><td>Inflamax</td><td>Farmaceutica</td></tr><tr><td>Inza</td><td>Alphapharm</td></tr><tr><td>Iraxen</td><td>Quilab</td></tr><tr><td>Jinkangpuli</td><td>Conba</td></tr><tr><td>Lexinax</td><td>Brisafarma</td></tr><tr><td>Melgar</td><td>Hexa</td></tr><tr><td>Messelxen</td><td>Biomep</td></tr><tr><td>Mobilat</td><td>STADA</td></tr><tr><td>NAPRELAN</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Naprometin</td><td>Roche</td></tr><tr><td>Naprosyn</td><td>Roche</td></tr><tr><td>Naprosyn CR</td><td>Abdi Ibrahim</td></tr><tr><td>Naprosyn EC</td><td>Roche</td></tr><tr><td>Naprosyn Entero</td><td>Roche</td></tr><tr><td>Naprosyn SR</td><td>Roche</td></tr><tr><td>Naprosyne</td><td>Roche</td></tr><tr><td>Naproval</td><td>Labinco</td></tr><tr><td>Naproxen</td><td>GlaxoSmithKline</td></tr><tr><td>Naprux</td><td>Andromaco</td></tr><tr><td>Neuralprona</td><td>Lba</td></tr><tr><td>Noflam</td><td>Mylan</td></tr><tr><td>Nopain</td><td>Medicef</td></tr><tr><td>Prexan</td><td>New Research</td></tr><tr><td>Priaxen</td><td>Remedica</td></tr><tr><td>Princeps</td><td>Laser </td></tr><tr><td>Pronaxen</td><td>Orion</td></tr><tr><td>Proxen</td><td>Gr&#252;nenthal</td></tr><tr><td>Proxen S</td><td>Roche</td></tr><tr><td>Proxen SR</td><td>Roche</td></tr><tr><td>Releve</td><td>General Pharma</td></tr><tr><td>Repro</td><td>Doctor's Chemical Works</td></tr><tr><td>Reuxen</td><td>Helcor</td></tr><tr><td>Riproxen</td><td>BioGenet</td></tr><tr><td>Sanaprox</td><td>Perumed</td></tr><tr><td>Seladin</td><td>YSP</td></tr><tr><td>Servinaprox</td><td>Novartis</td></tr><tr><td>Tarproxen</td><td>Polfa Tarchomin</td></tr><tr><td>Ticoflex</td><td>Incepta</td></tr><tr><td>Tundra</td><td>Frasca</td></tr><tr><td>Xenar</td><td>Elder</td></tr><tr><td>Xenar-CR</td><td>Elder</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Arthopan</td><td>Naproxen and Pantoprazole</td></tr><tr><td>Brunadol</td><td>Naproxen and Paracetamol</td></tr><tr><td>Lumbal Lafrancol</td><td>Naproxen and Caffeine</td></tr><tr><td>Momendol</td><td>Naproxen and Sulodexide</td></tr><tr><td>Neuralgesic</td><td>Naproxen and Paracetamol</td></tr><tr><td>Proxalin-Plus</td><td>Naproxen and Paracetamol</td></tr><tr><td>Sumigran</td><td>Naproxen and Sumatriptan</td></tr><tr><td>Vimovo</td><td>Naproxen and Esomeprazole</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>CAS number</th><td>22204-53-1</td></tr><tr><th>Weight</th><td>Average: 230.2592<br>Monoisotopic: 230.094294314</td></tr><tr><th>Chemical Formula</th><td>C<sub>14</sub>H<sub>14</sub>O<sub>3</sub></td></tr><tr><th>InChI Key</th><td>CMWTZPSULFXXJA-VIFPVBQESA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid</div></td></tr><tr><th>SMILES</th><td><div class="wrap">COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00788.gif?1265922772">show</a>(7.95 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Phenylpropanoids and Polyketides</td></tr><tr><th>Class</th><td>Phenylpropanoic Acids</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Phenylpropanoic Acids</td></tr><tr><th>Alternative parents</th><td>Naphthalenes; Anisoles; Alkyl Aryl Ethers; Enolates; Carboxylic Acids; Polyamines</td></tr><tr><th>Substituents</th><td>anisole; phenol ether; alkyl aryl ether; benzene; ether; carboxylic acid; carboxylic acid derivative; polyamine; enolate</td></tr><tr><th>Classification description</th><td>This compound belongs to the phenylpropanoic acids. These are compounds whose structure contain a benzene ring conjugated to a propanoic acid.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and acute gout. Also for the relief of mild to moderate pain and the treatment of primary dysmenorrhea.</td></tr><tr><th>Pharmacodynamics</th><td>Naproxen is a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs). Naproxen has analgesic and antipyretic properties. As with other NSAIDs, its mode of action is not fully understood; however, its ability to inhibit prostaglandin synthesis may be involved in the anti-inflammatory effect.</td></tr><tr><th>Mechanism of action</th><td>The mechanism of action of naproxen, like that of other NSAIDs, is believed to be associated with the inhibition of cyclooxygenase activity. Two unique cyclooxygenases have been described in mammals. The constitutive cyclooxygenase, COX-1, synthesizes prostaglandins necessary for normal gastrointestinal and renal function. The inducible cyclooxygenase, COX-2, generates prostaglandins involved in inflammation. Inhibition of COX-1 is thought to be associated with gastrointestinal and renal toxicity while inhibition of COX-2 provides anti-inflammatory activity.</td></tr><tr><th>Absorption</th><td>Naproxen itself is rapidly and completely absorbed from the GI tract with an in vivo bioavailability of 95%. Although naproxen itself is well absorbed, the sodium salt form is more rapidly absorbed resulting in higher peak plasma levels for a given dose. Food causes a slight decrease in the rate absorption.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>At therapeutic levels naproxen is greater than 99% albumin-bound.</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Naproxen is extensively metabolized to 6-0-desmethyl naproxen and both parent and metabolites do not induce metabolizing enzymes.</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Naproxen</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002793" target="_blank">Cytochrome P450 2C9</a></li>
<li><a href="/biodb/bio_entities/BE0002887" target="_blank">Cytochrome P450 2C8</a></li>
<li><a href="/biodb/bio_entities/BE0002433" target="_blank">Cytochrome P450 1A2</a></li></ul></td><td><a href="/metabolites/DBMET00159"><i>O</i>-Desmethylnaproxen</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/159">Details</a></td></tr><tr><td>Naproxen</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003541" target="_blank">UDP-glucuronosyltransferase 1-1</a></li>
<li><a href="/biodb/bio_entities/BE0003679" target="_blank">UDP-glucuronosyltransferase 2B7</a></li></ul></td><td><a href="/metabolites/DBMET00160">Naproxen <i>O</i>-glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/160">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00159"><i>O</i>-Desmethylnaproxen</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000927" target="_blank">Sulfotransferase 1A1</a></li>
<li><a href="/biodb/bio_entities/BE0000951" target="_blank">Estrogen sulfotransferase</a></li>
<li><a href="/biodb/bio_entities/BE0002561" target="_blank">Sulfotransferase family cytosolic 1B member 1</a></li></ul></td><td><a href="/metabolites/DBMET01259"><i>O</i>-Desmethylnaproxen sulfate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1418">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00159"><i>O</i>-Desmethylnaproxen</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0004859" target="_blank">UDP-glucuronosyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01260"><i>O</i>-Desmethylnaproxen acyl glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1419">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00159"><i>O</i>-Desmethylnaproxen</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0004859" target="_blank">UDP-glucuronosyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01261"><i>O</i>-Desmethylnaproxen <i>O</i>-glucuronide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1420">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td>The observed terminal elimination half-life is approximately 15 hours.</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>ORAL (LD<sub>50</sub>): Acute: 248 mg/kg [Rat]. 360 mg/kg [Mouse]. Symptoms of overdose include drowsiness, heartburn, indigestion, nausea, and vomiting.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9948</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.6881</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.9091</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.586</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8747</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8396</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8615</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7548</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5715</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Inhibitor</td>
        <td>0.9107</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.907</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9521</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9447</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8905</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.8598</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          AMES toxic 
        </td>
        <td>
            0.5184
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8685
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.7809
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.4579 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9588
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.9144
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Roche palo alto llc</li>
<li>Roxane laboratories inc</li>
<li>Actavis elizabeth llc</li>
<li>Alphapharm party ltd</li>
<li>Pliva inc</li>
<li>Sandoz inc</li>
<li>Teva pharmaceuticals usa inc</li>
<li>Amneal pharmaceuticals ny llc</li>
<li>Baxter healthcare corp anesthesia and critical care</li>
<li>Dava pharmaceuticals inc</li>
<li>Glenmark generics ltd</li>
<li>Hamilton pharmaceuticals ltd</li>
<li>Ivax pharmaceuticals inc sub teva pharmaceuticals usa</li>
<li>Mylan pharmaceuticals inc</li>
<li>Perrigo r and d co</li>
<li>Purepac pharmaceutical co</li>
<li>Teva pharmaceuticals usa</li>
<li>Watson laboratories inc</li>
<li>Westward pharmaceutical corp</li>
<li>Zydus pharmaceuticals usa inc</li>
<li>Banner pharmacaps inc</li>
<li>Stat trade inc</li>
<li>Watson laboratories inc florida</li>
<li>Bayer healthcare llc</li>
<li>Able laboratories inc</li>
<li>Contract pharmacal corp</li>
<li>Dr reddys laboratories inc</li>
<li>Dr reddys laboratories ltd</li>
<li>Hikma pharmaceuticals</li>
<li>L perrigo co</li></ul></td></tr><tr><th>Packagers</th><td><ul><li>Advanced Pharmaceutical Services Inc.</li>
<li><a href="http://www.aidarex.com">Aidarex Pharmacuticals LLC</a></li>
<li><a href="http://www.alturapharma.com">Altura Pharmaceuticals Inc.</a></li>
<li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li><a href="http://www.amneal.com">Amneal Pharmaceuticals</a></li>
<li>Apotheca Inc.</li>
<li>Apothecary Shop Wholesale</li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li><a href="http://www.astrazeneca.ca">AstraZeneca Inc.</a></li>
<li><a href="http://www.atlanticbiologicals.com">Atlantic Biologicals Corporation</a></li>
<li>Avkare Incorporated</li>
<li><a href="http://www.bayerhealthcare.com">Bayer Healthcare</a></li>
<li><a href="http://www.bpipack.com">Blenheim Pharmacal</a></li>
<li><a href="http://bryantranchprepack.com">Bryant Ranch Prepack</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li><a href="http://www.chaindrug.com">Chain Drug</a></li>
<li>Comprehensive Consultant Services Inc.</li>
<li><a href="http://www.corepharma.com">Corepharma LLC</a></li>
<li>Coupler Enterprises Inc.</li>
<li><a href="http://www.cvs.com">CVS Pharmacy</a></li>
<li><a href="http://www.davapharma.com">DAVA Pharmaceuticals</a></li>
<li>Dept Health Central Pharmacy</li>
<li>DHHS Program Support Center Supply Service Center</li>
<li>Direct Dispensing Inc.</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li><a href="http://www.drreddys.com">Doctor Reddys Laboratories Ltd.</a></li>
<li><a href="http://www.elan.com">Elan Pharmaceuticals Inc.</a></li>
<li><a href="http://www.ethex.com">Ethex Corp.</a></li>
<li><a href="http://www.roche.com">F Hoffmann-La Roche Ltd.</a></li>
<li><a href="http://www.glenmark-generics.com">Glenmark Generics Ltd.</a></li>
<li><a href="http://www.gsms.us">Golden State Medical Supply Inc.</a></li>
<li><a href="http://www.ghc.org">Group Health Cooperative</a></li>
<li><a href="http://hjharkinscompanyinc.com">H.J. Harkins Co. Inc.</a></li>
<li>Heartland Repack Services LLC</li>
<li><a href="http://www.hikma.com">Hikma Pharmaceuticals</a></li>
<li>Innovative Manufacturing and Distribution Services Inc.</li>
<li><a href="http://www.innoviantpharmacy.com">Innoviant Pharmacy Inc.</a></li>
<li><a href="http://www.intetlab.com">International Ethical Labs Inc.</a></li>
<li>Ivax Pharmaceuticals</li>
<li>Kaiser Foundation Hospital</li>
<li><a href="http://www.keltman.com">Keltman Pharmaceuticals Inc.</a></li>
<li>Lake Erie Medical and Surgical Supply</li>
<li><a href="http://www.legacypackaging.com">Legacy Pharmaceuticals Packaging LLC</a></li>
<li>Liberty Pharmaceuticals</li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.mediqueproducts.com">Medique Products</a></li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li><a href="http://www.medvantx.com">Medvantx Inc.</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li><a href="http://www.mylan.com">Mylan</a></li>
<li>Novopharm Ltd.</li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li><a href="http://www.palmettopharm.com">Palmetto Pharmaceuticals Inc.</a></li>
<li><a href="http://www.patheon.com">Patheon Inc.</a></li>
<li><a href="http://www.patientfirst.com">Patient First Corp.</a></li>
<li>PCA LLC</li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li><a href="http://www.perrigo.com">Perrigo Co.</a></li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li><a href="http://www.pharmedixrx.com">Pharmedix</a></li>
<li><a href="http://www.pharmpakinc.com">Pharmpak Inc.</a></li>
<li><a href="http://www.pplpho.org">Physician Partners Ltd.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.pliva.com">Pliva Inc.</a></li>
<li><a href="http://www.preferredpharmaceuticals.com">Preferred Pharmaceuticals Inc.</a></li>
<li>Prepackage Specialists</li>
<li><a href="http://www.prepaksys.com">Prepak Systems Inc.</a></li>
<li>Prescription Dispensing Service Inc.</li>
<li><a href="http://www.qpsrx.com">Quality Pharmaceuticals Services Inc.</a></li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li>Redpharm Drug</li>
<li><a href="http://www.remedyrepack.com">Remedy Repack</a></li>
<li>Resource Optimization and Innovation LLC</li>
<li><a href="http://www.roxane.com">Roxane Labs</a></li>
<li><a href="http://www.sandhillspackaging.com">Sandhills Packaging Inc.</a></li>
<li><a href="http://www.sandoz.ca">Sandoz</a></li>
<li><a href="http://www.southwoodhealthcare.com">Southwood Pharmaceuticals</a></li>
<li>St Mary's Medical Park Pharmacy</li>
<li><a href="http://statrxusa.exporterus.com">Stat Rx Usa</a></li>
<li>Talbert Medical Management Corp.</li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li>Tya Pharmaceuticals</li>
<li><a href="http://www.udllabs.com">UDL Laboratories</a></li>
<li>Va Cmop Dallas</li>
<li>Vangard Labs Inc.</li>
<li><a href="http://www.victorypharma.com">Victory Pharma</a></li>
<li><a href="http://www.walgreens.com">Walgreen Co.</a></li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li>
<li><a href="http://www.west-ward.com">West-Ward Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Suppository</td><td>Rectal</td><td></td></tr><tr><td>Suspension</td><td>Oral</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr><tr><td>Tablet, coated</td><td>Oral</td><td></td></tr><tr><td>Tablet, extended release</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><ul><li><a data-no-turbolink="true" href="/spectra/spectra/nmr_one_d/1802">1H NMR Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/1849">MS/MS Spectrum Quattro_QQQ 10</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/1850">MS/MS Spectrum Quattro_QQQ 25</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/1851">MS/MS Spectrum Quattro_QQQ 40</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5612">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5613">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5614">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5615">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5616">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5617">MS/MS Spectrum LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5618">MS/MS Spectrum LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/nmr_two_d/1742">[1H,13C] 2D NMR Spectrum</a></li></ul></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01418">Acenocoumarol</a></td><td>The NSAID, naproxen, may increase the anticoagulant effect of acenocoumarol.</td></tr><tr><td><a href="/drugs/DB00630">Alendronate</a></td><td>Increased risk of gastric toxicity</td></tr><tr><td><a href="/drugs/DB01125">Anisindione</a></td><td>The NSAID, naproxen, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB06605">Apixaban</a></td><td>Due to pharmacodynamic interaction, a 50-60% increase in anti-Factor Xa activity may be observed with concomitant therapy. </td></tr><tr><td><a href="/drugs/DB08822">Azilsartan medoxomil</a></td><td>Increases toxicity of each. May deteriorate renal function, particularly in volume depleted or elderly patients. Decreases effects of azilsartan by antagonism. </td></tr><tr><td><a href="/drugs/DB00930">Colesevelam</a></td><td>Bile acid sequestrants may decrease the absorption of Nonsteroidal Anti-Inflammatory Agents. Monitor for decreased serum concentrations/therapeutic effects of nonsteroidal anti-inflammatory agents (NSAID) if coadministered with bile acid sequestrants. Separating the administration of doses by 2 or more hours may reduce (but not eliminate) the risk of interaction. The manufacturer of colesevelam recommends that drugs should be administered at least 1 hour before or 4 hours after colesevelam. </td></tr><tr><td><a href="/drugs/DB00091">Cyclosporine</a></td><td>Monitor for nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00266">Dicoumarol</a></td><td>The NSAID, naproxen, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01381">Ginkgo biloba</a></td><td>Additive anticoagulant/antiplatelet effects may increase bleed risk. Concomitant therapy should be avoided.</td></tr><tr><td><a href="/drugs/DB01356">Lithium</a></td><td>The NSAID, naproxen, may decrease the renal excretion of lithium. Increased risk of lithium toxicity.</td></tr><tr><td><a href="/drugs/DB00563">Methotrexate</a></td><td>The NSAID, naproxen, may decrease the renal excretion of methotrexate. Increased risk of methotrexate toxicity.</td></tr><tr><td><a href="/drugs/DB06813">Pralatrexate</a></td><td>NSAIDs increase the risk of toxicity due to impairment of renal clearance of pralatrexate thus increasing exposure. Monitor for adverse effects or adjust dose of pralatrexate. </td></tr><tr><td><a href="/drugs/DB06204">Tapentadol</a></td><td>Increases the AUC of tapentadol by 17%. These changes are not considered clinically relevant and no change in dose is required.</td></tr><tr><td><a href="/drugs/DB00966">Telmisartan</a></td><td>Concomitant use of Telmisartan and Naproxen may increase the risk of acute renal failure and hyperkalemia. Monitor renal function at the beginning and during treatment. </td></tr><tr><td><a href="/drugs/DB00373">Timolol</a></td><td>The NSAID, Naproxen, may antagonize the antihypertensive effect of Timolol.</td></tr><tr><td><a href="/drugs/DB00519">Trandolapril</a></td><td>The NSAID, Naproxen, may reduce the antihypertensive effect of Trandolapril. Consider alternate therapy or monitor for changes in Trandolapril efficacy if Naproxen is initiated, discontinued or dose changed.  </td></tr><tr><td><a href="/drugs/DB00374">Treprostinil</a></td><td>The prostacyclin analogue, Treprostinil, may increase the risk of bleeding when combined with the NSAID, Naproxen. Monitor for increased bleeding during concomitant thearpy. </td></tr><tr><td><a href="/drugs/DB08814">Triflusal</a></td><td>The metabolite of triflusal, 2-hydroxy-4-trifluoro-methyl-benzoic acid (HTB), impairs the serum protein binding of naproxen to the same extent as acetylsalisylic acid. Thus, the free fraction of glisentide may be increased. A dosage reduction may be required if used in combination. </td></tr><tr><td><a href="/drugs/DB06684">Vilazodone</a></td><td>Increased risk of bleeding with concomitant use of NSAIDs with vilazodone.</td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>The antiplatelet effects of naproxen may increase the bleed risk associated with warfarin. Consider alternate therapy or monitor for signs and symptoms of bleeding during concomitant therapy.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid alcohol.</li>
<li>Take with a full glass of water.</li>
<li>Take with food.</li></ul></td></tr></tbody></table>